Sutter Health System, California; Health Care, Hospital; Health Care, System Apr 02

  • ID: 2044251
  • April 2002
  • Region: California
  • Standard & Poors
1 of 3

The 'A+' rating on California Statewide Communities Development Authority's revenue bonds series 2002A and 2002B, issued for Sutter Health System--as well as the affirmed 'A+' ratings on approximately $1.1 billion in outstanding debt issued for Sutter Health System--are based on: Relatively stable financial performance in fiscal 2001, sufficient to absorb the additional $152 million in new debt and still generate adequate coverage; and Sutter's solid market position in northern California, with 31 hospitals providing revenue diversity and negotiating leverage with payors. Mitigating factors include a relatively weak balance sheet for this rating level and a slight deterioration in Sutter's performance ratios as a function primarily of growth in operating budget, with more profound overall improvement in performance seemingly still somewhat...

Companies mentioned in this report are:
- Sutter Hlth
- California Statewide Communities Dev Auth

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Sutter Hlth
- California Statewide Communities Dev Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.